Argus
•
Apr 15, 2026
LNTH: Raising target price to $87.00
Summary
Lantheus Holdings Inc caters to the United States healthcare sector with the develop
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Merck & Co., Inc.
May 01, 2026
•
MRK
Analyst Report: AstraZeneca PLC
Apr 30, 2026
•
AZN
Analyst Report: Insulet Corporation
Apr 29, 2026
•
PODD
MEDP: Lowering target price to $455.00
Apr 29, 2026
•
MEDP
AMPH: Raising target price to $21.00
Apr 29, 2026
•
AMPH
